Price
No data yet.
Social Signal Score
Revenue
$272.70M+37.24%Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2021 | $937.00M | $49.00M | $1.78 |
| 2020 | $792.30M | $-900.0K | $-0.03 |
| 2019 | $812.00M | $-21.30M | $-0.84 |
| 2018 | $839.60M | $-6.40M | $-0.25 |
| 2017 | $753.20M | $-7.10M | $-0.29 |
Valuation
Project earnings forward and see what return today's price implies.
EPS was negative in at least one boundary year, so a compound growth rate can't be computed from it. Set your own assumption.
- EPS in 5 years
- $2.62
- Implied price
- $15.71
- Return from $10.70
- 8.0% a year
To earn 15.0% a year on these assumptions you'd need to buy at $7.81 — -27.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 2 | 4 | 6 | 8 | 10 |
|---|---|---|---|---|---|
| -2.0% | -21.3% | -9.6% | -2.0% | 3.8% | 8.5% |
| 3.0% | -17.3% | -5.0% | 3.0% | 9.1% | 14.1% |
| 8.0% | -13.3% | -0.4% | 8.0% | 14.4% | 19.6% |
| 13.0% | -9.3% | 4.2% | 13.0% | 19.7% | 25.1% |
| 18.0% | -5.3% | 8.8% | 18.0% | 25.0% | 30.7% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsthenewswire.com·5h ago·Neutral
…BA, as Chief Medical Officer to Support Next Phase of Clinical Development Vancouver, British Columbia – TheNewswire - August 17, 2026 – Helix BioPharma Corp. (TSX: “HBP” , OTC PINK: “HBPC F ” , FRANKFURT: “HBP0” ) ( “Helix” or the “Company” ), a clinical-stage oncology company developing novel therapies for difficult-to-treat cancers , today announced the appointment of Markus Loeffler, MD, MBA as Chief Medical Officer (CMO) of the Company. Dr. Loeffler's appointment comes as Helix prepares t…
View source ↗
Insider trading
Open-market buys and sells by HBP officers and directors.
- Bought
- $304k
- Sold
- $113k
8 trades
3 trades
- Fishbein Davidsold
- Fishbein Davidsold
- Tanner Delbert Hbought
- Tanner Delbert Hbought
- Tanner Delbert Hbought
- Glass Donald Lbought
- Glass Donald Lbought
- Tanner Delbert Hbought
89 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.